{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:46:11Z","timestamp":1782852371672,"version":"3.54.5"},"reference-count":17,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    IgG4-related disease is a fibro-inflammatory multisystemic condition with lesions mimicking tumors. Involvement of the hypophysis is rare and the first case of IgG4-related hypophysitis was described in 2004. Typically, it is revealed by sellar mass effects, hypopituitarism, and diabetes insipidus. In the present paper, we report a case of IgG4-related hypophysitis revealed by submandibular sialadenitis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Case Report.<\/jats:bold>\n                    The subject was a 52-year-old patient presented with swelling of the submandibular gland. His complaints were decreased libido, anorexia, and weight loss for three months. Hormonal assessment found mild hyperprolactinemia, hypogonadotropic hypogonadism, and central hypothyroidism. Pituitary magnetic resonance imaging showed heterogeneous enlargement of the pituitary gland with diffuse gadolinium enhancement. The submandibular gland biopsy revealed submandibular sialadenitis with positive immunohistochemistry to IgG4. Diagnosis of IgG4-related hypophysitis was made based on Leporati criteria 2 and 3. Glucocorticoid therapy was prescribed for this patient, but without improvement of the pituitary function. In fact, the effectiveness of steroid therapy on the pituitary swelling is proven and already represents the fifth diagnostic criterion of Leporati. However, the improvement of the pituitary functions is uncertain.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    The present case illustrates an atypical presentation of IgG4-related hypophysitis without tumor syndrome or diabetes insipidus. Continuous monitoring of the pituitary function is needed during the long-term follow up given that improvement of the hormonal deficiencies is uncertain.\n                  <\/jats:p>","DOI":"10.2478\/enr-2025-0014","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:12:02Z","timestamp":1756455122000},"page":"130-134","source":"Crossref","is-referenced-by-count":0,"title":["Atypical IgG4 related hypophysitis revealed by submandibular sialadenitis: a case report"],"prefix":"10.2478","volume":"59","author":[{"given":"Bilel Ben","family":"Amor","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"},{"name":"University of Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekram","family":"Hajji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Bayar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rym","family":"Mesfar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Saad","sequence":"additional","affiliation":[{"name":"Radiology Department , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Njim","sequence":"additional","affiliation":[{"name":"Anatomopathology Department , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanene","family":"Sayadi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Khochtali","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine , Fattouma Bourguiba University Hospital , Monastir , Tunisia"},{"name":"University of Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026063014592065714_j_enr-2025-0014_ref_001","doi-asserted-by":"crossref","unstructured":"Amirbaigloo A, Esfahanian F, Mouodi M, Rakhshani N, Zeinalizadeh M. IgG4-related hypophysitis. Endocrine 73, 270\u2013291, 2021.","DOI":"10.1007\/s12020-021-02714-0"},{"key":"2026063014592065714_j_enr-2025-0014_ref_002","doi-asserted-by":"crossref","unstructured":"Bashier AM, Harifi G, Abdelgadir EI. Igg4-related disorder and endocrine diseases: a review of the literature. J Diabetes Metab 6, 631, 2015.","DOI":"10.4172\/2155-6156.1000631"},{"key":"2026063014592065714_j_enr-2025-0014_ref_003","doi-asserted-by":"crossref","unstructured":"Bhargava R, Hussein Z, Dorward NL, Grieve JP, Jaunmuktane Z, Marcus HJ, Proctor I, Baldeweg SE. IgG4-related hypophysitis: a retrospective cohort study. Acta Neurochir (Wien) 164, 2095\u20132103, 2022.","DOI":"10.1007\/s00701-022-05231-9"},{"key":"2026063014592065714_j_enr-2025-0014_ref_004","doi-asserted-by":"crossref","unstructured":"Boharoon H, Tomlinson J, Limback-Stanic C, Gontsorova A, Martin N, Hatfield E, Meeran K, Nair R, Mendosa N, Levy J, McAdoo S, Pusey C, Wernig F. A case series of patients with isolated IgG4-related hypophysitis treated with rituximab. J Endocr Soc 4, bvaa048, 2020.","DOI":"10.1210\/jendso\/bvaa048"},{"key":"2026063014592065714_j_enr-2025-0014_ref_005","doi-asserted-by":"crossref","unstructured":"Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev 13, 1203\u20131210, 2014.","DOI":"10.1016\/j.autrev.2014.08.013"},{"key":"2026063014592065714_j_enr-2025-0014_ref_006","doi-asserted-by":"crossref","unstructured":"Khare S, Jagtap VS, Budyal SR, Kasaliwal R, Kakade HR, Bukan A, Sankhe S, Lila AR, Bandgar T, Menon PS, Shah NS. Primary (autoimmune) hypophysitis: a single centre experience. Pituitary 18, 16\u201322, 2015.","DOI":"10.1007\/s11102-013-0550-9"},{"key":"2026063014592065714_j_enr-2025-0014_ref_007","doi-asserted-by":"crossref","unstructured":"Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96, 1971\u20131980, 2011.","DOI":"10.1210\/jc.2010-2970"},{"key":"2026063014592065714_j_enr-2025-0014_ref_008","doi-asserted-by":"crossref","unstructured":"Li Y, Gao H, Li Z, Zhang X, Ding Y, Li F. Clinical characteristics of 76 patients with IgG4-related hypophysitis: a systematic literature review. Int J Endocrinol, 2019, 5382640, 2019.","DOI":"10.1155\/2019\/5382640"},{"key":"2026063014592065714_j_enr-2025-0014_ref_009","doi-asserted-by":"crossref","unstructured":"Lojou M, Bonneville JF, Ebbo M, Schleinitz N, Castinetti F. IgG4 hypophysitis: Diagnosis and management. Presse Med 49, 104016, 2020.","DOI":"10.1016\/j.lpm.2020.104016"},{"key":"2026063014592065714_j_enr-2025-0014_ref_010","doi-asserted-by":"crossref","unstructured":"Lv K, Cao X, Geng DY, Zhang J. Imaging findings of immunoglobin G4-related hypophysitis: A case report. World J Clin Cases 10, 9440\u20139446, 2022.","DOI":"10.12998\/wjcc.v10.i26.9440"},{"key":"2026063014592065714_j_enr-2025-0014_ref_011","doi-asserted-by":"crossref","unstructured":"Naik M, Hesni S, Tamimi A, Hameed M, Tomlinson J, Poo S, Tam F, Strickland N, Barwick TD, Harvey CV. Imaging manifestations of IgG4-related disease. Clin Radiol 78, 555\u2013564, 2023.","DOI":"10.1016\/j.crad.2023.03.003"},{"key":"2026063014592065714_j_enr-2025-0014_ref_012","unstructured":"Nambiar S, Oliver TI. IgG4-Related Disease. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499825\/"},{"key":"2026063014592065714_j_enr-2025-0014_ref_013","doi-asserted-by":"crossref","unstructured":"Nishi N, Takeshima K, Morita S, Iwakura H, Nishi M, Matsuoka T. Deterioration of pituitary function without relapse after steroid therapy for IgG4-related hypophysitis. Endocrinol Diabetes Metab Case Rep 2021, 21-0029, 2021.","DOI":"10.1530\/EDM-21-0029"},{"key":"2026063014592065714_j_enr-2025-0014_ref_014","doi-asserted-by":"crossref","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16, 702\u2013714, 2020.","DOI":"10.1038\/s41584-020-0500-7"},{"key":"2026063014592065714_j_enr-2025-0014_ref_015","doi-asserted-by":"crossref","unstructured":"Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, L\u00f6hr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Inebilizumab for treatment of IgG4-related disease. N Engl J Med 392, 1168-1177, 2025.","DOI":"10.1056\/NEJMoa2409712"},{"key":"2026063014592065714_j_enr-2025-0014_ref_016","doi-asserted-by":"crossref","unstructured":"Takagi H, Iwama S, Sugimura Y, Takahashi Y, Oki Y, Akamizu T, Arima H. Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society. Endocr J 67, 373\u2013378, 2020.","DOI":"10.1507\/endocrj.EJ19-0569"},{"key":"2026063014592065714_j_enr-2025-0014_ref_017","doi-asserted-by":"crossref","unstructured":"Wallace ZS, Katz G, Hernandez-Barco YG, Baker MC. Current and future advances in practice: IgG4-related disease. Rheumatol Adv Pract 8, rkae020, 2024.","DOI":"10.1093\/rap\/rkae020"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2025-0014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:45:26Z","timestamp":1782848726000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2025-0014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,1,1]]}},"alternative-id":["10.2478\/enr-2025-0014"],"URL":"https:\/\/doi.org\/10.2478\/enr-2025-0014","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}